Double-blind controlled clinical study of the efficacy and tolerability of diclofenac-N-(2-hydroxyethyl)-pyrrolidine lecithin gel compared with diclofenac-N-(2-hydroxyethyl)-pyrrolidine gel in patients with peri and extraarticular inflammatory diseases

Drugs under Experimental and Clinical Research

Volumn 25, Issue 5, 1999, Pages 235-240

  Fioravanti, A ^a   Cicero, M R ^a   Nerucci, F ^a   Manopulo, R ^b   Marcolongo, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Malpighi Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; N (2 HYDROXYETHYL) PYRROLIDINE; N (2 HYDROXYETHYL) PYRROLIDINE LECITHIN; PARACETAMOL; PYRROLIDINE DERIVATIVE; SKIN LIPID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MASSAGE; MULTICENTER STUDY; PAIN ASSESSMENT; PERIARTICULAR JOINT DISEASE; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE; SELF REPORT; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DOUBLE-BLIND METHOD; EDEMA; FEMALE; GELS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PAIN; PHOSPHATIDYLCHOLINES; RHEUMATIC DISEASES;

EID: 0032705459     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. th Interscience World Conf. Inflammation, Antirheumatics, Analgesics, Immunomodulators. Drugs Expt. Clin. Res., 19(3), 81, 1993.
2. Huskisson E.C. Measurement of pain. J. Rheumatol., 9, 768, 1984.
3. Calzigna L. Percutaneous absorption of diclofenac after topical application (Flector 1% gel and Voltarene 1% emulgel). Clin. Trials J., 26(5), 304, 1989.